This website contains information intended only for persons professionally dealing with medical devices (e.g. for persons performing medical professions, for persons dealing with the distribution of medical devices). Please confirm that you are a medical device professional to proceed.
August 30, 2022
Atherosclerosis and the coronary artery disease that progresses with it is the most common cause of heart failure. In Poland, more than 700k patients suffer from it, leading to the death of nearly 60k people a year. It is a disease that affects large and medium-sized arterial vessels. The mechanism of atherosclerosis is related to local lipid deposition inside the vessel wall and the formation of atherosclerotic plaque, which causes thickening of the wall, narrowing of the artery, as a result of which the vascular flow can be significantly reduced.
Most common symptoms of this disease are:
– worse exercise tolerance, shortness of breath, chest pains (so-called coronary pains)
– dizziness, disorientation, transient difficulty speaking, temporary paresis
– abdominal pains
– pain in the calves (known as “stopping chrome“), cramps, swelling in the legs and feet, tingling
– kidney failure, severe hypertension.
Symptoms depend on the type of atherosclerosis. Prevention involving, among others, a healthy diet, regular physical activity and giving up stimulants is essential. It will reduce the risk of dangerous consequences, such as heart attack, stroke or lower limb amputation.
Early diagnostics offer the chance to improve prognosis and implement an appropriate treatment plan as soon as possible.
March 1, 2023
Rebranding is a process aimed at changing one or more elements of a brand’s image communication. This includes changes...
February 24, 2023
The research project ‘HEMOFLOW cloud platform for non-invasive hemodynamic diagnostics’, No. POIR.01.01.01-00-0393/19, aims to assess the diagnostic value of...
January 11, 2023
What is FFR Measuring fractional flow reserve (FFR) is currently the ‘gold standard’ in the diagnostic assessment of coronary...
November 21, 2022
On 10 November at the ISPOR 2022 Europe conference, independent research company Panaxea presented the results of a study...
October 11, 2022
On October 7-8th, 2022 the 14th edition of the “New developments in interventional cardiology” congress took place in Augustow (Poland),...
September 26, 2022
On 22.09.2022, during the XXVI International Congress of the Polish Cardiac Society in Katowice, a specially appointed PTK Competition...
September 2, 2022
Cardiolens FFR-CT Pro® is a precise diagnostic test, supporting doctors in diagnosing patients with suspected ischemic heart disease. Cardiolens...
August 19, 2022
The Hemolens research project aims to assess the diagnostic value of the Hemolens platform for comprehensive, non-invasive diagnostics of...